These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9474440)

  • 1. Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?
    Carpenter WT; Zito JM; Vitrai J; Volavka J
    Biol Psychiatry; 1998 Jan; 43(2):79-83. PubMed ID: 9474440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine2 receptor occupancy and the action of clozapine: does it make a difference to add a neuroleptic?
    Meltzer HY
    Biol Psychiatry; 1999 Jul; 46(1):144-9. PubMed ID: 10394487
    [No Abstract]   [Full Text] [Related]  

  • 3. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients.
    Farde L; Nordström AL
    Br J Psychiatry Suppl; 1992 May; (17):30-3. PubMed ID: 1358126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in efficacy on substance abuse between risperidone and clozapine supports the importance of differential modulation of dopaminergic neurotransmission.
    Machielsen MW; de Haan L
    Psychopharmacol Bull; 2009; 42(4):40-52. PubMed ID: 20581792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
    Ewald HL; Mors NP; Rosenberg R
    Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.
    Pickar D; Su TP; Weinberger DR; Coppola R; Malhotra AK; Knable MB; Lee KS; Gorey J; Bartko JJ; Breier A; Hsiao J
    Am J Psychiatry; 1996 Dec; 153(12):1571-8. PubMed ID: 8942453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of dopamine D2 receptors in the CNS inhibits sympathetic cutaneous vasomotor alerting responses (SCVARs), contributing to clozapine's SCVAR-inhibiting action.
    Blessing WW; Ootsuka Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):328-36. PubMed ID: 17055139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo occupation of dopamine D1, D2 and serotonin (5-HT)2A receptors by sertindole in the rat brain.
    Takahashi Y; Kusumi I; Ishikane T; Matsubara S; Koyama T
    J Psychiatry Neurosci; 1998 May; 23(3):157-62. PubMed ID: 9595889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of D1-D2 receptor hetero-dimerization in the mechanism of action of clozapine.
    Faron-Górecka A; Górecki A; Kuśmider M; Wasylewski Z; Dziedzicka-Wasylewska M
    Eur Neuropsychopharmacol; 2008 Sep; 18(9):682-91. PubMed ID: 18550344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine and typical antipsychotics.
    Ross DE
    Am J Psychiatry; 2004 Oct; 161(10):1925-6. PubMed ID: 15465996
    [No Abstract]   [Full Text] [Related]  

  • 13. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
    Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose loxapine in the treatment of schizophrenia: is it more effective and more "atypical" than standard-dose loxapine?
    Meltzer HY; Jayathilake K
    J Clin Psychiatry; 1999; 60 Suppl 10():47-51. PubMed ID: 10340687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
    Talvik M; Nordström AL; Nyberg S; Olsson H; Halldin C; Farde L
    Am J Psychiatry; 2001 Jun; 158(6):926-30. PubMed ID: 11384901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of schizophrenic symptoms and changes in plasma HVA concentrations, plasma anti-D2 and anti-5-HT2 receptor activities with clozapine.
    Yamada K; Kanba S; Wang ZC; Suzuki E; Fang YY; Yan HG; Nibuya M; Yagi G; Asai M
    Psychiatry Clin Neurosci; 1996 Oct; 50(5):291-4. PubMed ID: 9201793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action.
    Kapur S; McClelland RA; VanderSpek SC; Wadenberg ML; Baker G; Nobrega J; Zipursky RB; Seeman P
    Neuroreport; 2002 May; 13(6):831-5. PubMed ID: 11997696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical psychopharmacology: the example of clozapine (Leponex)].
    Péré JJ
    Encephale; 1995 Jun; 21 Spec No 3():9-12. PubMed ID: 7628347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacology of clozapine.
    Coward DM
    Br J Psychiatry Suppl; 1992 May; (17):5-11. PubMed ID: 1358127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.
    Seeman P
    Neuropsychopharmacology; 1992 Dec; 7(4):261-84. PubMed ID: 1362057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.